Mirtazapin Ratiopharm (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonising 5‑HT2 and 5‑HT3 serotonin receptors. This dual action enhances overall serotonergic and noradrenergic neurotransmission while reducing certain serotonergic side‑effects, leading to improved mood and sleep.

The appropriate dose of Mirtazapin Ratiopharm is determined by the prescribing clinician based on the individual’s clinical condition, response to therapy, and tolerability. Dosage adjustments are made during treatment, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for mirtazapine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Mirtazapin Ratiopharm. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mirtazapin Ratiopharm belongs to the NaSSA class, which differs from selective serotonin reuptake inhibitors (SSRIs) by also increasing norepinephrine and blocking specific serotonin receptors. This profile often results in stronger sedative and appetite‑stimulating effects, making it useful when insomnia or weight loss are concerns, whereas SSRIs tend to have fewer metabolic side‑effects.

Store the tablets at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Mirtazapin Ratiopharm is taken orally, and the tablets can be swallowed whole, placed under the tongue (sublingual) or against the cheek (buccal) as directed by the prescriber. It is usually taken once daily, preferably in the evening to take advantage of its sedative properties.

Serious adverse events include agranulocytosis or severe neutropenia, hepatic dysfunction, serotonin syndrome when combined with other serotonergic drugs, and the emergence or worsening of suicidal thoughts, particularly during the initial weeks of therapy. Patients should be monitored closely for any signs of these conditions.

Mirtazapin Ratiopharm should be avoided in individuals with known hypersensitivity to mirtazapine or any excipients, those currently taking monoamine oxidase inhibitors (MAOIs) or who have taken an MAOI within the past 14 days, and patients with severe hepatic impairment. Consultation with a healthcare professional is essential before starting therapy.